In contrast to RPs, most ADRs inhibited γH2AX and p-4EBP1 and activated p-AKT and p-STAT5, a signature of cell survival signaling in leukemia cells that, while demonstrative of the ability of the approach to identify contrasting mechanisms, is not ideal for cancer research. The gene discussed is AKT1; the disease is cancer.